Latest Royalties News

Strata Investment Holdings delivered a £16.48 million comprehensive profit for H1 2026, driven by a strong revaluation of its investment portfolio and maiden royalty income from Botswana copper assets.

Nickel Industries surged to a US$74 million profit in H1 2026, driven by higher nickel prices, expanded mining quotas, and strategic HPAL investments including first nickel cathode production at ENC.

Acrux Limited reported a 46% revenue increase to $6.6 million in FY26, driven by US generic product royalties and licensing milestones, while narrowing its net loss by 90%. The company is pivoting towards developing a female testosterone therapy with encouraging Phase II data and active regulatory engagement.

Neuren Pharmaceuticals reported an 8% rise in H1 2026 revenues driven by DAYBUE royalties, but profit fell 68% due to ramped-up R&D. The company declared its first ever dividend, signalling confidence amid ongoing clinical and regulatory milestones.

Calix Limited posted a 16% revenue increase to $39.2 million in FY26 driven by strong growth in its Magnesia business, while reporting a substantial net loss of $51 million largely due to a one-off impairment. The company advanced key industrial decarbonisation projects and strengthened strategic partnerships, focusing on capital-light commercialisation.

Taiton Resources has secured a farm-in agreement over EL 6468, significantly enlarging its Challenger West gold-copper project in South Australia. Historic drilling highlights shallow, high-grade mineralisation, while new soil sampling aims to sharpen upcoming drill targets.

Ore Resources Ltd (ASX: OR3) has released a robust Scoping Study for its Kangaroo Hills Lithium Project, outlining a low-capital, fast-track Direct Shipping Ore (DSO) operation expected to generate substantial cash flow within a 16-month mine life.

Bayan Mining has finalised the sale of its Bayan Springs North Project to Sun Silver, securing upfront and contingent payments while retaining a 1% royalty to maintain exposure to future exploration success.

Sinclair Gold has cleared a key drilling milestone at its Mt Henry project, prompting a $5 million cash payment to Westgold and cancelling over 7.5 million performance rights. The company also moves closer to completing a royalty deal with Stria Lithium, while preparing for a resource update by year-end.

Brisbane Broncos Limited reported a 33% jump in half-year profit before tax to $11.57 million, fuelled by higher crowds, membership, and merchandise sales despite a slight dip in ARLC funding.

St George Mining has formally begun environmental permitting for its Araxá Project in Brazil, submitting key assessments to Minas Gerais regulators as it moves toward developing a rare earths and niobium mine.

Neuren Pharmaceuticals’ partner Acadia Pharmaceuticals secured European Commission approval for DAYBU (trofinetide) to treat Rett syndrome symptoms in patients aged five and older, marking the first EU-authorised treatment for this condition.